NASDAQ:CSX • US1264081035
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CSX CORP (CSX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-23 | Bernstein | Maintains | Market Perform -> Market Perform |
| 2026-01-23 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2026-01-23 | Citigroup | Maintains | Buy -> Buy |
| 2026-01-12 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-12-08 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-20 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-20 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-10-20 | Baird | Maintains | Outperform -> Outperform |
| 2025-10-17 | TD Cowen | Maintains | Buy -> Buy |
| 2025-10-17 | UBS | Maintains | Buy -> Buy |
| 2025-10-17 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-10-17 | Raymond James | Reiterate | Outperform -> Outperform |
| 2025-10-17 | Jefferies | Maintains | Buy -> Buy |
| 2025-10-13 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-08 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-10-03 | UBS | Maintains | Buy -> Buy |
| 2025-09-26 | Baird | Maintains | Outperform -> Outperform |
| 2025-09-25 | Susquehanna | Maintains | Neutral -> Neutral |
| 2025-09-25 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2025-09-24 | B of A Securities | Maintains | Buy -> Buy |
| 2025-09-18 | RBC Capital | Upgrade | Sector Perform -> Outperform |
| 2025-08-18 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2025-07-25 | Baird | Maintains | Outperform -> Outperform |
| 2025-07-24 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-07-24 | Benchmark | Maintains | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 14.657B -1.32% | 14.54B -0.80% | 14.092B -3.08% | 14.625B 3.78% | 15.295B 4.58% | 15.897B 3.94% | 16.705B 5.08% | 17.218B 3.07% | 17.977B 4.41% | |
| EBITDA YoY % growth | 7.072B -2.92% | 7B -1.02% | 6.365B -9.07% | 6.921B 8.74% | 7.415B 7.14% | 7.72B 4.11% | 8.224B 6.53% | 8.813B 7.16% | N/A | |
| EBIT YoY % growth | 5.465B -5.53% | 5.342B -2.25% | 4.685B -12.30% | 5.228B 11.59% | 5.671B 8.47% | 6.003B 5.85% | 6.332B 5.48% | 6.673B 5.39% | 7.093B 6.29% | |
| Operating Margin | 37.29% | 36.74% | 33.25% | 35.75% | 37.08% | 37.76% | 37.90% | 38.76% | 39.46% | |
| EPS YoY % growth | 1.84 -3.66% | 1.83 -0.54% | 1.61 -12.02% | 1.86 15.70% | 2.11 13.01% | 2.30 9.24% | 2.48 8.04% | 2.59 4.07% | 2.82 8.98% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.40 18.05% | 0.49 11.45% | 0.50 13.21% | 0.49 26.53% | 0.48 18.69% | 0.55 13.04% | 0.56 11.99% | 0.56 12.70% |
| Revenue Q2Q % growth | 3.534B 3.24% | 3.687B 3.16% | 3.758B 4.77% | 3.801B 8.35% | 3.757B 6.31% | 3.912B 6.10% | 3.937B 4.76% | 3.968B 4.39% |
| EBITDA Q2Q % growth | 1.592B 8.59% | 1.803B -15.39% | 1.835B -27.21% | 1.81B -35.13% | 1.782B 11.93% | 1.934B 7.27% | 1.934B 5.40% | 1.931B 6.69% |
| EBIT Q2Q % growth | 1.168B 12.20% | 1.378B 7.74% | 1.394B 11.97% | 1.356B 22.16% | 1.312B 12.33% | 1.488B 7.98% | 1.484B 6.46% | 1.469B 8.33% |
All data in USD
30 analysts have analysed CSX and the average price target is 40.7 USD. This implies a price decrease of -0.52% is expected in the next year compared to the current price of 40.91.
CSX CORP (CSX) will report earnings on 2026-04-14.
The consensus EPS estimate for the next earnings of CSX CORP (CSX) is 0.4 USD and the consensus revenue estimate is 3.53B USD.
The number of analysts covering CSX CORP (CSX) is 30.